Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis-Reference-Cited by-同舟云学术

Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis

Published:2024-03-13 Issue:5 Volume:31 Page:766-777
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Werner Marcela S.,Aras Shweta,Morgan Ashleigh R.,Roamer Jillian,Param Nesteene J.,Olagbegi Kanyin,Lamontagne R. Jason^ORCID,Greig Jenny A.,Wilson James M.^ORCID

Funder

This study was supported by G2 Oncology.

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41417-024-00751-1.pdf

Reference51 articles.

1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75.

2. American Cancer Society: Survival Rates for Breast Cancer: American Cancer Society; [updated March 1, 2022. Available from https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html.

3. Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al. Adjuvant trastuzumab in HER2-positive breast cancer. N. Engl J Med. 2011;365:1273–83.

4. Vu T, Claret FX. Trastuzumab: updated mechanisms of action and resistance in breast cancer. Front Oncol. 2012;2:62.

5. Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, et al. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature. 2003;421:756–60.